Kuantum Papers [KUANTUM] vs Valiant Organics [VALIANTORG] Detailed Stock Comparison
Kuantum Papers
NSE
Loading...
Valiant Organics
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kuantum Papers wins in 15 metrics, Valiant Organics wins in 4 metrics, with 0 ties. Kuantum Papers appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kuantum Papers | Valiant Organics | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.75 | 184.84 | Kuantum Papers |
| Price-to-Book Ratio | 0.79 | 1.35 | Kuantum Papers |
| Debt-to-Equity Ratio | 53.90 | 34.30 | Valiant Organics |
| PEG Ratio | -0.16 | -0.13 | Kuantum Papers |
| EV/EBITDA | 7.76 | 19.77 | Kuantum Papers |
| Profit Margin (TTM) | 8.49% | 0.67% | Kuantum Papers |
| Operating Margin (TTM) | 11.31% | 7.54% | Kuantum Papers |
| EBITDA Margin (TTM) | 11.31% | 7.54% | Kuantum Papers |
| Return on Equity | 9.50% | -0.52% | Kuantum Papers |
| Return on Assets (TTM) | 5.45% | -0.32% | Kuantum Papers |
| Free Cash Flow (TTM) | $-1.36B | $256.03M | Valiant Organics |
| Dividend Yield | 5.07% | N/A | N/A |
| 1-Year Return | -22.67% | -13.79% | Valiant Organics |
| Price-to-Sales Ratio (TTM) | 0.92 | 1.32 | Kuantum Papers |
| Enterprise Value | $16.01B | $12.35B | Kuantum Papers |
| EV/Revenue Ratio | 1.53 | 1.64 | Kuantum Papers |
| Gross Profit Margin (TTM) | 50.77% | 38.46% | Kuantum Papers |
| Revenue per Share (TTM) | $120 | $248 | Valiant Organics |
| Earnings per Share (Diluted) | $10.20 | $1.92 | Kuantum Papers |
| Beta (Stock Volatility) | -0.22 | 0.11 | Kuantum Papers |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Kuantum Papers vs Valiant Organics Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kuantum Papers | 0.81% | 0.48% | -3.60% | -4.84% | 5.21% | -18.29% |
| Valiant Organics | 4.59% | 10.55% | 9.43% | -15.08% | 47.48% | 19.54% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kuantum Papers | -22.67% | -5.02% | 156.01% | 122.54% | 122.54% | 122.54% |
| Valiant Organics | -13.79% | -52.43% | -77.83% | -77.83% | -77.83% | -77.83% |
News Based Sentiment: Kuantum Papers vs Valiant Organics
Kuantum Papers
News based Sentiment: MIXED
The month presented a mixed picture for Kuantum Papers, with a strong full-year performance contrasted by a weaker first quarter due to planned machine upgrades. While the company is investing in future growth, short-term headwinds and valuation concerns create a complex investment scenario.
Valiant Organics
News based Sentiment: POSITIVE
Valiant Organics reported exceptional Q1 results with substantial growth in revenue and net profit. While the stock is currently trading at a discount to its estimated fair value, the 'weak' price trend and mixed analyst sentiment introduce some caution. Overall, the month's developments suggest a positive, but not entirely risk-free, investment opportunity.
Performance & Financial Health Analysis: Kuantum Papers vs Valiant Organics
| Metric | KUANTUM | VALIANTORG |
|---|---|---|
| Market Information | ||
| Market Cap | ₹9.58B | ₹10.00B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 90,708 | 10,120 |
| 90 Day Avg. Volume | 67,455 | 15,209 |
| Last Close | ₹111.88 | ₹389.70 |
| 52 Week Range | ₹95.23 - ₹151.00 | ₹227.05 - ₹507.80 |
| % from 52W High | -25.91% | -23.26% |
| All-Time High | ₹225.85 (Aug 21, 2023) | ₹1,991.00 (Dec 21, 2020) |
| % from All-Time High | -50.46% | -80.43% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.21% | 0.22% |
| Quarterly Earnings Growth | -0.68% | 0.22% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.01% |
| Operating Margin (TTM) | 0.11% | 0.08% |
| Return on Equity (TTM) | 0.10% | -0.01% |
| Debt to Equity (MRQ) | 53.90 | 34.30 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹138.97 | ₹262.55 |
| Cash per Share (MRQ) | ₹1.06 | ₹2.73 |
| Operating Cash Flow (TTM) | ₹1.67B | ₹832.88M |
| Levered Free Cash Flow (TTM) | ₹1.15B | ₹-37,360,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 5.07% | N/A |
| Last 12-Month Dividend | ₹6.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Kuantum Papers vs Valiant Organics
| Metric | KUANTUM | VALIANTORG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.75 | 184.84 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.16 | -0.13 |
| Price to Sales (TTM) | 0.92 | 1.32 |
| Price to Book (MRQ) | 0.79 | 1.35 |
| Market Capitalization | ||
| Market Capitalization | ₹9.58B | ₹10.00B |
| Enterprise Value | ₹16.01B | ₹12.35B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.53 | 1.64 |
| Enterprise to EBITDA | 7.76 | 19.77 |
| Risk & Other Metrics | ||
| Beta | -0.22 | 0.11 |
| Book Value per Share (MRQ) | ₹138.97 | ₹262.55 |
Financial Statements Comparison: Kuantum Papers vs Valiant Organics
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KUANTUM | VALIANTORG |
|---|---|---|
| Revenue/Sales | ₹2.22B | ₹2.04B |
| Cost of Goods Sold | ₹1.09B | ₹1.26B |
| Gross Profit | ₹1.13B | ₹786.15M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹252.00M | ₹154.09M |
| EBITDA | ₹418.30M | ₹265.27M |
| Pre-Tax Income | ₹162.40M | ₹111.07M |
| Income Tax | ₹41.80M | ₹29.05M |
| Net Income (Profit) | ₹120.60M | ₹82.03M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KUANTUM | VALIANTORG |
|---|---|---|
| Cash & Equivalents | ₹92.38M | ₹70.97M |
| Total Current Assets | ₹2.71B | ₹3.56B |
| Total Current Liabilities | ₹3.27B | ₹3.69B |
| Long-Term Debt | ₹4.03B | ₹508.22M |
| Total Shareholders Equity | ₹12.13B | ₹7.25B |
| Retained Earnings | ₹11.47B | N/A |
| Property, Plant & Equipment | ₹16.01B | ₹6.44B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KUANTUM | VALIANTORG |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KUANTUM | VALIANTORG |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 90,708 | 10,120 |
| Average Daily Volume (90 Day) | 67,455 | 15,209 |
| Shares Outstanding | 87.26M | 28.00M |
| Float Shares | 18.39M | 9.50M |
| % Held by Insiders | 0.77% | 0.66% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Kuantum Papers vs Valiant Organics
| Metric | KUANTUM | VALIANTORG |
|---|---|---|
| Last 12-Month Dividend | ₹6.00 | ₹0.00 |
| Last 12-Month Dividend Yield | 5.07% | N/A |
| 3-Year Avg Annual Dividend | ₹3.00 | ₹1.50 |
| 3-Year Avg Dividend Yield | 2.04% | 0.35% |
| 3-Year Total Dividends | ₹9.00 | ₹4.50 |
| Ex-Dividend Date | Aug 22, 2025 | Feb 10, 2023 |